Thursday, 15 October 2026European Markets

PLASTIC OMNIUM, IBERSOL,SGPS, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - plastic omnium (pom.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
plastic omnium (pom.pa) €16.33 2.32% 8.97%
ibersol,sgps (ibs.ls) €6.64 2.15% 35.54%
bains mer monaco (bain.pa) €96.00 1.03% 86.62%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. plastic omnium (pom.pa)

2.32% forward dividend yield and 8.97% return on equity

compagnie plastic omnium se engages in the manufacture and sale of exterior vehicle lighting systems, batteries, and electrification systems for electric mobility in europe, north america, asia, south america, and africa. the company operates through industries and modules segments. its industries segment provides intelligent exterior systems; clean energy systems comprising internal combustion engines dedicated to energy storage system and emission reduction system, and on-board batteries, power electronics, and electrification systems for electric mobility of trucks, buses, coaches, trains, and construction machinery; new energies, such as hydrogen fuel cells and fuel tanks; and automotive lighting systems and varroc lighting systems. the company's modules segment engages in the design, development, and assemble of modules. in addition, the company provides intelligent exterior systems, including bumpers, tailgates and spoilers, and body panels; onboard energy storage and emission reduction systems comprising selective catalytic reduction and fuel systems, and filling pipes; and hydrogen solutions, such as high-pressure hydrogen storage, fuel cell stack, and integrated hydrogen system. further, it offers modules and personalization products, which include front-end module, active grille shutter, active rollo, and interior and charge lid modules; and lighting solutions, including interior, body shell, and front and signal lighting, as well as projection system and lighting electronics. the company was founded in 1946 and is headquartered in levallois-perret, france. compagnie plastic omnium se is a subsidiary of burelle sa.

earnings per share

as for profitability, plastic omnium has a trailing twelve months eps of €1.16.

pe ratio

plastic omnium has a trailing twelve months price to earnings ratio of 14.08. meaning, the purchaser of the share is investing €14.08 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.97%.

volume

today's last reported volume for plastic omnium is 12420 which is 89.87% below its average volume of 122691.

yearly top and bottom value

plastic omnium's stock is valued at €16.33 at 02:30 est, way below its 52-week high of €19.87 and way above its 52-week low of €12.92.

more news about plastic omnium.

2. ibersol,sgps (ibs.ls)

2.15% forward dividend yield and 35.54% return on equity

ibersol, s.g.p.s., s.a., through its subsidiaries, operates a network of restaurants in portugal, spain, and angola. the company operates restaurants under various brands, including pizza hut, pasta caffé, pans & company, ribs, fresco, santamaria, kentucky fried chicken, burger king, o' kilo, quiosques, pizza móvil, miit, taco bell, sol, silva carvalho catering e palace catering, travel, coffee counters, and other concessions contract. the company was founded in 1989 and is headquartered in porto, portugal. ibersol, s.g.p.s., s.a. is a subsidiary of atps - sgps, s.a.

earnings per share

as for profitability, ibersol,sgps has a trailing twelve months eps of €1.98.

pe ratio

ibersol,sgps has a trailing twelve months price to earnings ratio of 3.35. meaning, the purchaser of the share is investing €3.35 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.54%.

more news about ibersol,sgps.

3. bains mer monaco (bain.pa)

1.03% forward dividend yield and 86.62% return on equity

société anonyme des bains de mer et du cercle des étrangers à monaco operates in the gaming, hotels, and rental sectors in monaco. the company operates casinos; hotels; restaurants; lounge bars and nightclubs; wellness and leisure facilities; shows and concert halls; shopping centers; and meetings and events centers. it is also involved in the slot machines, table games, and other activities; and rental of shops, offices, shop windows, villas, luxury residential, etc. properties. in addition, the company offers catering services. the company was incorporated in 1863 and is headquartered in monaco.

earnings per share

as for profitability, bains mer monaco has a trailing twelve months eps of €39.22.

pe ratio

bains mer monaco has a trailing twelve months price to earnings ratio of 2.45. meaning, the purchaser of the share is investing €2.45 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 86.62%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, bains mer monaco's stock is considered to be overbought (>=80).

revenue growth

year-on-year quarterly revenue growth grew by 38.8%, now sitting on 651.45m for the twelve trailing months.

yearly top and bottom value

bains mer monaco's stock is valued at €96.00 at 02:30 est, under its 52-week high of €99.00 and way above its 52-week low of €63.20.

more news about bains mer monaco.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com